Prospective Observational Study for Determination of Minimal Clinically Important Difference of Allergic Rhinitis Symptoms Due to Grass Pollen (Equinoxe 2)

Allergic Rhinitis Due to Grass Pollen Clinical Trial

Official title:
Determination of Minimal Clinically Important Difference of Allergic Rhinitis Symptoms Due to Grass Pollen by the Assessment of the Relationship Between the Symptom Scores and Global Rating of Change Questionnaires on the Quality of Life and Well-being.

Status Completed

Clinical Trial Summary

Prospective multi-center study carried out in France involving patients with allergic rhinitis. Study in usual care where no specific diagnostic or therapeutic procedure is required. The patients will be asked to fill in Questionnaires on a daily and weekly basis.

Clinical Trial Description

n/a

Study Design

Observational Model: Case-Only, Time Perspective: Prospective

Related Conditions & MeSH terms

Allergic Rhinitis Due to Grass Pollen
Rhinitis
Rhinitis, Allergic

Clinical Trial Details

NCT number	NCT01953471
Study type	Observational
Source	Hopital Foch
Contact
Status	Completed
Phase	N/A
Start date	April 2011
Completion date	December 2011

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03290248` - Study to Assess the Safety, Tolerability, and Preliminary Efficacy of B244 in Healthy Volunteers and Subjects With Seasonal Allergic Rhinitis	Phase 1/Phase 2
Completed	`NCT06104293` - Determination of Grass Pollen Allergen Concentration Inducing Rhinoconjunctivitis Symptoms in Subjects Allergic to Grass Pollen in ALYATEC Allergen Exposure Chamber	N/A
Completed	`NCT04878237` - Kinetics of Nasal Cytokine Responses to Mechanical Stimulation	N/A
Completed	`NCT04802616` - The Influence of Nonspecific Immunostimulation on Changes in the Concentration of iNKT Cells	Phase 3
Active, not recruiting	`NCT05297760` - Intralymphatic Immunotherapy With Polvac Grass & Rye Allergen Extract	Phase 1/Phase 2
Recruiting	`NCT06061848` - Intralymphatic Immunotherapy Enhanced by Vitamin-D, a Randomized Placebo-controlled Trial and Comparison With SLIT	Phase 2/Phase 3
Completed	`NCT05037955` - ILIT: Follow-up of Rhinitis Quality of Life
Not yet recruiting	`NCT04700852` - Efficacy of Puressentiel Protective Nasal Spray in Allergic Rhinitis	N/A
Active, not recruiting	`NCT05191186` - Documentation of Efficacy of Intralymphatic Allergen Immunotherapy	Phase 3
Completed	`NCT04210193` - Is Intralymphatic Allergen Immunotherapy Effective and Safe?	Phase 2/Phase 3